To further assess the clinical relevance of miR-505 in hypertension-associated inflammation, the circulating level of miR-505 was examined in an independent cohort of previously untreated hypertensive patients along with that of CRP, a well-established biomarker of inflammation closely associated with the development of hypertension and endothelial dysfunction (13). Here, CRP is linked to hypertensive disorder.